Pancreatic Cancer Research

ResearcherUniversity of California, San FranciscoNo recent work listed

Evan Justin Walker

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3081-190X; OpenAlex author ID A5066609901. Sources: OpenAlex.

Their work

Papers
9 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2014: 1 paper · 2015: 2 papers · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper

Papers 9

  1. Maintenance Treatment for Metastatic Pancreatic Cancer: Balancing Therapeutic Intensity with Tolerable Toxicity. Co-author DOI 10.3390/cancers15143657↗
  2. The Additional Diagnostic Benefit of Pancreatic Cancer Molecular Profiling After Germline Testing. Co-author DOI 10.1097/mpa.0000000000002021↗
  3. Implementation of an Embedded In-Clinic Genetic Testing Station to Optimize Germline Testing for Patients with Pancreatic Adenocarcinoma. Co-author DOI 10.1002/onco.13968↗
  4. Durable response after immune checkpoint inhibitor-related diabetes in mismatch repair-deficient pancreatic cancer. First author DOI 10.2217/imt-2021-0008↗
  5. Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma. Co-author DOI 10.1007/s10689-018-0106-2↗
  6. A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000000458↗
  7. Statin use and risk of pancreatic cancer: results from a large, clinic-based case-control study. Co-author DOI 10.1002/cncr.29256↗
  8. Metformin use among type 2 diabetics and risk of pancreatic cancer in a clinic-based case-control study. Co-author DOI 10.1002/ijc.29120↗
  9. Beyond first-line chemotherapy for advanced pancreatic cancer: an expanding array of therapeutic options? Co-author DOI 10.3748/wjg.v20.i9.2224↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrew H. Ko · 7 shared papers, 2015–2023 · strength 1.08
  2. Julia C. Carnevale · 4 shared papers, 2019–2022 · strength 0.57
  3. Margaret A. Tempero · 4 shared papers, 2016–2022 · strength 0.45
  4. Pelin Cinar · 2 shared papers, 2021–2022 · strength 0.30
  5. Eric Andrew Collisson · 2 shared papers, 2019–2021 · strength 0.22
  6. Eric Andrew Collisson · 1 shared paper, 2022 · strength 0.17
  7. George Albert Fisher · 1 shared paper, 2021 · strength 0.17
  8. Erica S. Tsang · 1 shared paper, 2021 · strength 0.17
  9. Paige M. Bracci · 2 shared papers, 2015 · strength 0.14
  10. Mallika Dhawan · 1 shared paper, 2021 · strength 0.12
  11. Noelle K. LoConte · 1 shared paper, 2016 · strength 0.05
  12. Daniel V.T. Catenacci · 1 shared paper, 2016 · strength 0.05
  13. Hedy Lee Kindler · 1 shared paper, 2016 · strength 0.05
  14. Alan Paul Venook · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.